Charity BreakdownCanadian charity filings, itemized

Shwachman Diamond Syndrome Canada

Charitable organization · Mississauga, Ontario · BN 868808197RR0001 · Core Health Care · website

Your $100, itemizedShwachman Diamond Syndrome CanadaFiscal year ended December 31, 2023
Other$90
Management & admin$10
TOTAL$100
Registered

Source: T3010 return, FPE 2023-12-31. Split of total expenditures ($37,594) as filed with the CRA.

Shwachman Diamond Syndrome Canada is a charitable organization based in Mississauga, Ontario, classified by the CRA under core health care. In its fiscal year ending December 31, 2023, it reported -$176 in revenue and $38K in expenditures.

In 2024, 1 other registered charity reported granting it a combined $173.

Revenue has declined over its filings on record here, from $3,009 in 2020 to -$176 in 2023. Its filed list of directors and trustees shows 6 names.

In its own words

The organization is principally involved in raising funds for medical research and education in respect of shwachman diamond syndrome and providing a central canadian resource for families' and individuals doctors and donors.

Ongoing-program description from its T3010 filing, verbatim.

The ledger, 20202023

YearRevenueSpendingProgramsFundraisingGifts outNet assets
2023-$176$38K-$1,593
2022$2,735$4,998$32$36K
2021$5,331$4,808$420$38K
2020$3,009$23K$19K$38K

Revenue printed in red where the year ran a deficit. Fiscal years by period end.

Money between charities, 2024

Received $173 from 1 charity:

As reported on the donors’ own T3010 qualified-donee schedules.

Directors & trustees (2023)

Greg Symons (secretary); Heather Norton (director); Janice Pilgrim (director); Kimberly Smyth (director); Zoe Nataka (president); Lynda Ellis (director).

As listed on its 2023 return.

Check the source

Every figure on this page is from Shwachman Diamond Syndrome Canada’s own T3010 filings, published by the Canada Revenue Agency. Verify against the CRA’s charities listing (search BN 868808197RR0001), or read how we compute the receipt.